Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-24 @ 11:30 PM
NCT ID:
NCT07163156
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosis of idiopathic Parkinson's disease confirmed by a neurologist
* Both male and postmenopausal female patients
* Patients able to provide informed consent
* Clinically stable enough to undergo blood and saliva sampling, as well as neurological assessment
Exclusion Criteria:
* Premenopausal female patients
* Patients with secondary or atypical parkinsonism (e.g., drug-induced, vascular, atypical parkinsonian syndromes)
* Known endocrine disorders affecting prolactin levels (e.g., prolactinoma, pituitary adenoma, hypothyroidism)
* Use of medications known to alter prolactin secretion (e.g., antipsychotics, dopamine antagonists, estrogen therapy)
* History of other neurodegenerative diseases (e.g., Alzheimer's, Huntington's)
* Presence of active infection, chronic inflammatory disease, or malignancy
* Severe renal, hepatic, or cardiac failure
* Inability to provide informed consent
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07163156
Study Brief:
Protocol Section:
NCT07163156